Clinical trial
S0009 Combination Chemo and Surgery in Stage III or Stage IV Ovarian Cancer
NCT00008138 · SWOG Cancer Research Network, Other · Completed
Key facts
| NCT number | NCT00008138 |
|---|---|
| Title | S0009 Combination Chemo and Surgery in Stage III or Stage IV Ovarian Cancer |
| Official title | Phase II Evaluation Of Neoadjuvant Chemotherapy, Interval Debulking Followed By Intraperitoneal Chemotherapy In Women With Stage III And IV Epithelial Ovarian Cancer, Fallopian Tube Cancer Or Primary Peritoneal Cancer |
| Acronym | S0009 |
| Lead sponsor | SWOG Cancer Research Network, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cavity Cancer |
| Intervention type | Drug, Procedure |
| Interventions | carboplatin, paclitaxel, debulking surgery |
| Enrollment | 62 |
| Start date | Mar 1, 2001 |
| Primary completion | Sep 1, 2009 |
| Completion | Nov 1, 2009 |
| First posted | Jan 27, 2003 |
| Last update posted | Jan 8, 2016 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: